Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
Gary M. Hunninghake(Hubei University of Science and Technology), Iván O. Rosas(Brigham and Women's Hospital), Luisa D. Quesada-Arias(Pulmonary and Critical Care Associates), Hilary J. Goldberg(Harvard University), Rachel K. Putman(Brigham and Women's Hospital), Souheil El‐Chemaly(AVEO Oncology (United States)), Benjamin A. Raby(Brigham and Women's Hospital), Sergio Poli(Brigham and Women's Hospital), Jose Manuel Martinez Manzano(Pulmonary and Critical Care Associates), Hiroto Hatabu(Harvard University), Swati Gulati(Pulmonary and Critical Care Associates), S. Gampala-Sagar, Nikkola Carmichael(Boston University), Maura Alvarez Baumgartner(Pulmonary and Critical Care Associates), L. Digianni(Boston Children's Hospital), Dominick Leone
American Journal of Respiratory and Critical Care Medicine
February 3, 2020
Cited by 104
Related Papers
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
Serum Vitamin D Levels and Markers of Severity of Childhood Asthma in Costa Rica
|American Journal of Respiratory and Critical Care Medicine|2009|635
Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities
|New England Journal of Medicine|2011|615
MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis
|PLoS Medicine|2008|599